| Enumerate various indicators related to fetal death. (DNB 2025/1) 4 | P1 | 2025 |
| Write briefly on Poshan Abhiyan (National Nutrition Mission). (DNB 2025/1) 3 | P1 | 2025 |
| Standardized mortality ratio (SMR) and its importance in pediatrics. (DNB 2025/1) 3 | P1 | 2025 |
| Enumerate the technique and precautions while collecting blood samples for arterial blood gas analysis. (DNB 2025/1) 5 | P1 | 2025 |
| Causes of metabolic acidosis in a child. (DNB 2025/1) 5 | P1 | 2025 |
| Home Based Newborn Care program (HBNC). (DNB 2025/1) 4 | P1 | 2025 |
| Discuss the following in children between 0-18 years of age: (i) Parameters to detect undernutrition. [3] (ii) Parameters to detect overnutrition. (DNB 2025/1) 3 | P1 | 2025 |
| Role of Accredited Social Health Activist (ASHA) worker in neonatal and child health. (DNB 2025/1) 5 | P1 | 2025 |
| Home - based care for young child (HBYC). (DNB 2025/1) 5 | P1 | 2025 |
| Cluster randomized trial. (DNB 2025/1) 5 | P1 | 2025 |
| Components of patient Information sheet in study design. (DNB 2025/1) 5 | P1 | 2025 |
| Define brain death in neonate and in a child. (DNB 2025/1) 5 | P1 | 2025 |
| Physiological changes and principles of management of hyponatremia in a child. (DNB 2025/1) 5 | P1 | 2025 |
| Advantages and disadvantages of case-control study design. (DNB 2025/1) 5 | P1 | 2025 |
| Interpretation of linear correlation coefficient ‘r’. (DNB 2025/1) 5 | P1 | 2025 |
| Types of maltreatment of a child. (DNB 2025/1) 5 | P1 | 2025 |
| Adverse Events Following Immunisation (AEFI). (DNB 2025/1) 5 | P1 | 2025 |
| Relative risk and Odds ratio. (DNB 2025/1) 4 | P1 | 2025 |
| Enumerate types of Study design. (DNB 2025/1) 2 | P1 | 2025 |
| Role of Clinical Trials Registry of India (CTRI). (DNB 2025/1) 4 | P1 | 2025 |
| Babinski sign and various techniques to elicit it. (DNB 2025/1) 5 | P1 | 2025 |
| Systemic response to blood loss in a child. (DNB 2025/1) 5 | P1 | 2025 |
| Role of antenatal steroids in prevention of preterm morbidity. (DNB 2025/2) 5 | P2 | 2025 |
| Ultrasound detection of prenatal anomalies. (DNB 2025/2) 5 | P2 | 2025 |
| Diagnosis of pheochromocytoma in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Manifestations of vitamin A deficiency in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Management of Frequently Relapsing Nephrotic Syndrome (FRNS) in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Complex febrile seizures in a child. (DNB 2025/2) 5 | P2 | 2025 |
| ​ Discuss enuresis in a child under the following headings:- Types of enuresis. [2] Management of nocturnal enuresis. (DNB 2025/2) 3 | P2 | 2025 |
| ​ Investigations to differentiate proximal and distal renal tubular acidosis. (DNB 2025/2) 5 | P2 | 2025 |
| Laboratory findings and management of Autoimmune Hemolytic Anemia (AIHA) in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Chelation therapy in a child with thalassemia major on transfusion therapy. (DNB 2025/2) 5 | P2 | 2025 |
| Modes of neonatal ventilation. (DNB 2025/2) 5 | P2 | 2025 |
| Red blood cell exchange transfusion in a newborn. (DNB 2025/2) 5 | P2 | 2025 |
| Prenatal diagnosis of Down’s syndrome. (DNB 2025/2) 5 | P2 | 2025 |
| Neonatal morbidity associated with oligohydramnios and polyhydramnios in pregnancy. (DNB 2025/2) 5 | P2 | 2025 |
| Age independent anthropometric assessment in children. (DNB 2025/2) 5 | P2 | 2025 |
| Flow cytometry: Principles and application in diagnosis. (DNB 2025/2) 5 | P2 | 2025 |
| Vitamins and breast milk. (DNB 2025/2) 5 | P2 | 2025 |
| Varicella Zoster Immuno-Globulin (VZIG). (DNB 2025/2) 5 | P2 | 2025 |
| Epileptic encephalopathies in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Herpes Simplex viral encephalitis in a child. (DNB 2025/2) 5 | P2 | 2025 |
| Approach to management of tachyarrythmias in a child. (DNB 2025/3) 5 | P3 | 2025 |
| Wolf Parkinson White (WPW) syndrome. (DNB 2025/3) 5 | P3 | 2025 |
| Diagnostic criteria of Kawasaki disease and its management in children. (DNB 2025/3) 5 | P3 | 2025 |
| Discuss hyperaldosteronism in a child under following headings: Etiology. [3] Algorithmic approach to diagnosis using lab tests. (DNB 2025/3) 2 | P3 | 2025 |
| Screening tests for diagnosis of cushing's syndrome in children. (DNB 2025/3) 5 | P3 | 2025 |
| Management of neurocysticercosis in children. (DNB 2025/3) 5 | P3 | 2025 |
| Causes and management of chronic diarrhea in children. (DNB 2025/3) 5 | P3 | 2025 |
| Clinical features and management of autoimmune hepatitis in children. (DNB 2025/3) 5 | P3 | 2025 |
| Persistent pneumonia in children. (DNB 2025/3) 5 | P3 | 2025 |
| Temper tantrums. (DNB 2025/3) 5 | P3 | 2025 |
| Conduct disorders. (DNB 2025/3) 5 | P3 | 2025 |
| Define clinical exome sequencing (CES) and its uses. (DNB 2025/3) 5 | P3 | 2025 |
| Diagnosis and management of phenylketonuria. (DNB 2025/3) 5 | P3 | 2025 |
| Diagnostic criteria of tuberous sclerosis complex. (DNB 2025/3) 5 | P3 | 2025 |
| Discuss cataract in a child under following headings : Clinical presentation & etiology. [3] Management. (DNB 2025/3) 2 | P3 | 2025 |
| Management options of atopic dermatitis in children. (DNB 2025/3) 5 | P3 | 2025 |
| Lund and Browder diagram for estimating burns in children. (DNB 2025/3) 5 | P3 | 2025 |
| Management of corrosive poisonings in children. (DNB 2025/3) 5 | P3 | 2025 |
| Components of high-quality chest compressions in basic life support. (DNB 2025/3) 5 | P3 | 2025 |
| Healthcare-associated infections. (DNB 2025/3) 5 | P3 | 2025 |
| Discuss mechanism of tubular reabsorption in kidneys with the help of a diagram. (DNB 2025/4) 5 | P4 | 2025 |
| Referral criteria for growth-related problems in children. (DNB 2025/4) 5 | P4 | 2025 |
| Changes in respiratory mechanics in a newborn after birth. (DNB 2025/4) 5 | P4 | 2025 |
| Clinical approach to microcytic anemia in a child. (DNB 2025/4) 5 | P4 | 2025 |
| Drugs used in pulmonary hypertension. (DNB 2025/4) 5 | P4 | 2025 |
| Nadas criteria for the diagnosis of congenital heart disease. (DNB 2025/4) 5 | P4 | 2025 |
| Discuss human leucocyte antigen (HLA) and its role in transplantation. (DNB 2025/4) 5 | P4 | 2025 |
| Hematopoietic stem cell transplantation in a child. (DNB 2025/4) 5 | P4 | 2025 |
| Brighton diagnostic criteria for Guillain-Barre syndrome. (DNB 2025/4) 5 | P4 | 2025 |
| Inhalation devices used in the management of chronic childhood asthma. (DNB 2025/4) 5 | P4 | 2025 |
| Prevention of medication errors in NICU. (DNB 2025/4) 5 | P4 | 2025 |
| Enumerate the changes in neonatal resuscitation program (NRP) India 2024 over NRP AHA 2020, and their implications. (DNB 2025/4) 5 | P4 | 2025 |
| Initial management of the septic shock in resource-poor countries as per recent surviving sepsis guidelines. (DNB 2025/4) 5 | P4 | 2025 |
| Rapid malaria antigen test. (DNB 2025/4) 5 | P4 | 2025 |
| Yellow fever vaccine in children. (DNB 2025/4) 5 | P4 | 2025 |
| Cardiac action potential in various part of heart. (DNB 2025/4) 5 | P4 | 2025 |
| Vaughan William classification for antiarrhythmic medications. (DNB 2025/4) 5 | P4 | 2025 |
| Pulmonary function tests. (DNB 2025/4) 5 | P4 | 2025 |
| Embryonic development of diaphragm & its abnormalities leading to congenital diaphragmatic hernia (CDH). (DNB 2025/4) 5 | P4 | 2025 |
| Pathophysiology of acute rheumatic fever. (DNB 2025/4) 5 | P4 | 2025 |